Due to its infrequent occurrence, there is a paucity of specific management guidelines, with treatment generally following the protocols applied to more common breast cancer subtypes. Here, we report the case of a 54-year-old woman with HER2-positive apocrine breast carcinoma and a solitary bone metastasis in the L5 vertebra. This evidence concerns the gene ERBB2 and breast cancer.